Skip to main content

Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases

Abstract

Although it is still debated whether chronic cerebro-spinal venous insufficiency (CCSVI) plays a role in multiple sclerosis (MS) development, many patients underwent endovascular treatment (ET) of CCSVI. The objective of the study is to evaluate the outcome and safety of ET in Italian MS patients. Italian MS centers that are part of the Italian MS Study Group were all invited to participate to this retrospective study. A structured questionnaire was used to collect detailed clinical data before and after the ET. Data from 462 patients were collected in 33 centers. ET consisted of balloon dilatation (93 % of cases) or stent application. The mean follow-up duration after ET was 31 weeks. Mean EDSS remained unchanged after ET (5.2 vs. 4.9), 144 relapses occurred in 98/462 cases (21 %), mainly in RR-MS patients. Fifteen severe adverse events were recorded in 3.2 % of cases. Given the risk of severe adverse events and the lack of objective beneficial effects, our findings confirm that at present ET should not be recommended to patients with MS.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Zamboni P (2006) The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med 99:589–593

    PubMed  Article  Google Scholar 

  2. 2.

    Zamboni P, Menegatti E, Bartolomei I et al (2007) Intracranial venous haemodynamics in multiple sclerosis. Curr Neurovasc Res 4:252–258

    PubMed  Article  Google Scholar 

  3. 3.

    Zamboni P, Galeotti R, Menegatti E et al (2009) Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 80:392–399

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Zamboni P, Menegatti E, Galeotti R et al (2009) The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci 282:21–27

    PubMed  Article  Google Scholar 

  5. 5.

    Thapar A, Lane T, Nicholas R, Friede T et al (2011) Systematic review of sonographic chronic cerebrospinal venous insufficiency findings in multiple sclerosis. Phlebology 26(8):319–325

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Baracchini C, Atzori M, Gallo P (2012) CCSVI and MS: no meaning, no fact. Neurol Sci May 9 (Epub ahead of print)

  7. 7.

    Bagert BA, Marder E, Stüve O (2011) Chronic cerebrospinal venous insufficiency and multiple sclerosis. Arch Neurol 68:1379–1384

    PubMed  Article  Google Scholar 

  8. 8.

    Kipshidze N, Rukhadze I, Archvadze A et al (2011) Endovascular treatment of patients with chronic cerebrospinal venous insufficiency and multiple sclerosis. Georgian Med News 199:29–34

    PubMed  Google Scholar 

  9. 9.

    Mandato KD, Hegener PF, Siskin GP et al (2012) Safety of endovascular treatment of chronic cerebrospinal venous insufficiency: a report of 240 patients with multiple sclerosis. J Vasc Interv Radiol 23:55–59

    PubMed  Article  Google Scholar 

  10. 10.

    Kostecki J, Zaniewski M, Ziaja K et al (2011) An endovascular treatment of chronic cerebro-spinal venous insufficiency in multiple sclerosis patients—6 month follow-up results. Neuro Endocrinol Lett 32:557–562

    PubMed  Google Scholar 

  11. 11.

    Zamboni P, Galeotti R, Weinstock-Guttman B et al (2012) Venous angioplasty in patients with multiple sclerosis: results of a pilot study. Eur J Vasc Endovasc Surg 43:116–122

    PubMed  Article  CAS  Google Scholar 

  12. 12.

    Petrov I, Grozdinski L, Kaninski G (2011) Safety profile of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Endovasc Ther 18:314–323

    PubMed  Article  Google Scholar 

  13. 13.

    Ludyga T, Kazibudzki M, Simka M et al (2010) Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe? Phlebology 25:286–295

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Zamboni P, Galeotti R, Menegatti E et al (2009) A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 50:1348–1358

    PubMed  Article  Google Scholar 

  15. 15.

    Salvi F, Bartolomei I, Buccellato E et al (2012) Venous angioplasty in multiple sclerosis: neurological outcome at two years in a cohort of relapsing-remitting patients. Funct Neurol 27:55–59

    PubMed  Google Scholar 

  16. 16.

    http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm303318.htm#.T6vm8Mc8cjc.email

  17. 17.

    Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability scale (EDSS). Neurology 33:1444–1452

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Ghezzi A. Annovazzi P, Amato MP et al. (2013) Adverse events after endovascular treatment of chronic cerebrospinal venous insufficiency (CCSVI) in patients with multiple sclerosis Mult Scler J (in press)

Download references

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to A. Ghezzi.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 14 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ghezzi, A., Annovazzi, P., Cocco, E. et al. Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. Neurol Sci 34, 1633–1637 (2013). https://doi.org/10.1007/s10072-013-1300-5

Download citation

Keywords

  • Multiple sclerosis
  • CCSVI
  • Endovascular treatment